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Two Cases of Kerstersia gyiorum Isolated from Sites of Chronic
Infection
Morgan A. Pence,a Jeffrey Sharon,b Erin McElvania Tekippe,a Brittany L. Pakalniskis,c Bradley A. Ford,c Carey-Ann D. Burnhama
Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine,a and Department of Otolaryngology,b Washington University School of
Medicine, St. Louis, Missouri, USA; Department of Pathology, University of Iowa, Iowa City, Iowa, USAc
Kerstersia gyiorum is infrequently associated with human infection. We report the isolation of Kerstersia gyiorum from two pa-
tients: the first, a patient with chronic ear infections, and the second, a patient with a chronic leg wound. Both isolates were resis-
tant to ciprofloxacin, which has not been previously reported.
CASE REPORTS
Case 1. A 55-year-old man with a past medical history of chronicear disease, alcoholism, and smoking (2 packs/day) was seen in
the Barnes-Jewish Hospital otolaryngology clinic with a chief com-
plaint of bilateral ear drainage. At the ages of 13 and 16, he had un-
dergone canal wall-down mastoidectomies of the right and left ears,
respectively. Since that time, he had reported some hearing loss and
bilateral ear drainage. One month prior to his current encounter, the
patient complained of increasing drainage from his left ear, which
reportedly exhibited a reddish hue and an odor of “dead fish.” At that
time, the patient was prescribed 0.3% ciprofloxacin–0.1% dexa-
methasone otic solution (four drops, twice daily). At a follow-up visit
1 month later, he admitted to being only partially compliant with his
prescribed regimen. During the same visit, the left mastoid cavity was
suctioned and cleaned and a specimen was taken from the posterior
pocket at the sinodural angle and submitted for aerobic bacterial cul-
ture. The patient was instructed to continue using ciprofloxacin-
dexamethasone drops and expressed that he would make an effort to
be more compliant.
The direct Gram stain of the specimen submitted from the
mastoid cavity showed no polymorphonuclear cells, moderate
numbers of Gram-positive bacilli, and moderate numbers of
Gram-negative bacilli. The culture grew abundant amounts of
Corynebacterium amycolatum, as well as an abundant amount of a
Gram-negative coccobacillus, which appeared in singles, pairs,
and short chains on Gram stain (Fig. 1A). The isolate formed flat,
opaque, gray colonies with spreading edges on blood (Fig. 1B) and
chocolate agar, with a colony morphology somewhat resembling
that of Alcaligenes spp. but lacking the characteristic “fruity” odor
associated with this genus. On MacConkey agar, the isolate was
non-lactose fermenting, but colonies had a slight lavender hue
(Fig. 1C), which was especially evident when the colonies were
picked up using a swab (Fig. 1D). The isolate was oxidase negative,
spot indole negative, catalase positive, and nonmotile. An oxida-
tion/fermentation (OF) glucose test was performed; the isolate
was found to be a nonutilizer of glucose. Disks containing vanco-
mycin and penicillin were added to subculture plates to obtain
additional information about the isolate; there was no inhibition
around the vancomycin disk, and a zone size of 16 mm was mea-
sured around the penicillin disk. A Vitek 2 Gram-negative identi-
fication (GNI) card (bioMérieux, Durham, NC) resulted in no
identification. A RapID NF plus assay (Thermo Fisher Scientific,
Lenexa, KS) was performed and gave a biocode of 010200, which
resulted in an identification of Pseudomonas oryzihabitans (64.6%
confidence),Burkholderia cepacia (34.5% confidence), orAcineto-
bacter spp. (0.85% confidence). The isolate was subsequently an-
alyzed by matrix-assisted laser desorption ionization–time of
flight (MALDI-TOF) mass spectrometry (MS) and identified as
Kerstersia gyiorum on the BioTyper system (software version 3.0;
Bruker-Daltonics, Billerica, MA). BioTyper scores of 2.3 and 2.4
(excellent identification) were obtained with and without a formic
acid overlay, respectively (1). The isolate was unidentified on the
Vitek MS (database version 2.0; bioMérieux). However, K. gyio-
rum is not present in the Vitek MS database. The identification of
K. gyiorum by MALDI-TOF was confirmed by 16S rRNA gene
sequencing using previously described methodology (2, 3). The
sequence was 100% identical to K. gyiorum using the NCBI nr/nt
database; the next nearest matches were Bordetella spp. (96% se-
quence homology) and Achromobacter spp. (95% sequence ho-
mology).
The patient was scheduled for follow-up in the otolaryngology
clinic 2, 4, and 6 weeks later, but he did not present for his ap-
pointments. During a telephone consultation 6 weeks postculture,
he reported continued ear drainage and was prescribed 2 weeks of
trimethoprim-sulfamethoxazole based on antimicrobial suscepti-
bility data. During a subsequent clinic visit 1 week later, the pa-
tient reported that drainage had stopped.
Case 2. A 54-year-old morbidly obese woman was admitted
to the University of Iowa Hospitals and Clinics (UIHC) in July
2006 for lower leg cellulitis, for which she was treated with
ceftriaxone and vancomycin with clinical improvement.
Wound cultures were not collected prior to the initiation of
antibiotics, and superficial swabs of the wound collected post-
treatment were negative for bacterial growth. After being lost
to follow-up in August 2006, the patient presented to the UIHC
burn clinic in January 2013, at age 61, with a nonhealing, grad-
ually enlarging, 10-cm ulcer on her left lower leg. During the
intervening years, the wound had been managed with topical
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nifedipine, skin ointment, hydrocortisone, and according to
the patient, a number of different types of systemic antibiotics
(not further specified).
A direct Gram stain of the swab specimen revealed a few
polymorphonuclear cells and moderate numbers of Gram-neg-
ative bacilli. The culture of the wound grew abundant amounts
of Morganella morganii and a second Gram-negative rod,
which formed colonies with spreading edges on blood and
chocolate agar. The isolate was oxidase negative and motile,
and colonies on MacConkey agar displayed a lavender pigment
when picked up on a swab. An API 20NE (bioMérieux) was
performed and gave a biocode of 0000053, which provided an
identification of Alcaligenes faecalis (58% confidence) or Acin-
etobacter baumannii/calcoaceticus (37% confidence). The iso-
late was subsequently analyzed as previously described for non-
fermenting Gram-negative bacilli (1) by MALDI-TOF MS
using the Bruker MALDI BioTyper system (software version
3.1), which resulted in an identification of Kerstersia gyiorum
with scores of 2.3 and 2.24 (excellent identification) with a
formic acid overlay. As with the isolate in the first case, the
identification of K. gyiorum by MALDI-TOF was confirmed by
16S rRNA gene sequencing; the IDNS SmartGene system (ver-
sion 3.6.10; SmartGene GmbS, Lausanne, Switzerland) was
used to identify the isolate as K. gyiorum according to the stan-
dards published in the Clinical and Laboratory Standards In-
stitute (CLSI) document MM18-A (4). The sequence was
99.8% identical to K. gyiorum type strain LMG 5906 using the
NCBI 16S rRNA gene database. The next-nearest matches were
Bordetella, Alcaligenes, Pusillimonas, and Castellaniella spp.
with 93% homology.
Susceptibly testing on this isolate was performed using the Sen-
sititre GN3F panel (Thermo Scientific). The isolate tested as sus-
ceptible to cefepime (4 g/ml), gentamicin (2 g/ml), mero-
penem (1 g/ml), piperacillin-tazobactam (16 g/ml), and
trimethoprim-sulfamethoxazole (0.5 g/ml) and intermediate
to ciprofloxacin (2 g/ml). The patient was treated with 500 mg
ciprofloxacin orally, twice daily for 10 days, based on case reports
demonstrating susceptibility of K. gyiorum isolates to ciprofloxa-
cin (5, 6). Subsequently, an Etest battery was performed on both
isolates for comparison between the two institutions (7) (Table 1).
Follow-up information regarding the patient’s antimicrobial reg-
imen was not available.
The novel genus Kerstersia, first proposed in 2003 by Coenye
et al., is a member of the family Alcaligenaceae and is closely
related to Alcaligenes, Bordetella, and Achromobacter spp., al-
though it is oxidase negative, in contrast to the other genera
(5). The initial publication describing this genus included nine
isolates recovered from leg wounds, sputum, and feces. Be-
cause most strains had been isolated from leg wounds, gyiorum,
meaning “from the limbs,” was selected as the species name.
Since that time, there have been only two additional publica-
tions describing Kerstersia isolated from human clinical speci-
mens (6, 8). The first isolate (Kerstersia similis) was isolated
from a neck abscess of a 54-year-old male, and the second (K.
gyiorum) was isolated from a 16-year-old male with cholestea-
tomatous chronic otitis media. As our first patient also suffers
from chronic ear disease, it is plausible that K. gyiorum may
FIG 1 Phenotypic characteristics of Kerstersia gyiorum. (A) K. gyiorum appears as Gram-negative coccobacilli in singles, pairs, and short chains on Gram stain.
(B) On blood agar, the K. gyiorum isolates appeared as gray colonies with spreading edges. (C, D) Both isolates showed a slight lavender hue on MacConkey agar
(C), which was prominent when the colonies were picked up on a swab (D).
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have a predilection or tropism for causing infections in patients
with chronic otitis media. However, we do not know the con-
tribution of this patient’s alcoholism and/or smoking history in
this infection.
The biochemical characteristics of the isolates were in ac-
cordance with those previously published: oxidase negative,
catalase positive, and glucose negative (5, 6). Variability in mo-
tility was seen between the two isolates; this has also been pre-
viously reported (5). Because of the unusual nature of these
isolates, it is unlikely that we would have been able to assign an
identification solely using biochemical methods. However, it
should be noted that the second isolate generated an API 20NE
biocode identical to that of the isolate described by Almuzara et
al. (6). K. gyiorum is not included in the databases of most
commercial systems, and thus, the possibility exists that oxi-
dase-negative organisms with the same biocode may be identi-
fiable as K. gyiorum.
There are no prior descriptions of this species exhibiting a
spreading edge morphology on blood and chocolate agar or the
presence of lavender pigment on MacConkey agar, but based on
these two cases, it seems that these phenotypes may be character-
istic of K. gyiorum. The spreading morphology distinguishes K.
gyiorum from Acinetobacter spp., which are also oxidase-negative,
nonfermenting Gram-negative bacilli that are able to take up crys-
tal violet from MacConkey agar.
In the era of molecular diagnostics in the clinical microbi-
ology laboratory, technologies such as 16S rRNA gene sequenc-
ing and MALDI-TOF MS are important contributors to the
identification of new and rare taxa from clinical specimens.
Identification of these novel taxa can highlight two important
questions: (i) are these isolates truly rare causes of human dis-
ease, or have they historically been unidentified and/or mis-
identified, and (ii) how are clinical laboratories to perform
susceptibility testing on these isolates to help guide clinicians
in the selection of appropriate antimicrobial therapy? As iden-
tification methods such as MALDI-TOF and 16S rRNA gene
sequencing become more widely adopted in clinical laborato-
ries, atypical taxa will continued to be identified. While more
frequent identification of these isolates may help to solidify the
epidemiological context for such organisms, it is unlikely that
standardized CLSI criteria for antimicrobial susceptibility test-
ing and interpretation of results will be established in the near
future. Thus, the approach in the Barnes-Jewish laboratory for
susceptibility testing of unusual, clinically important, nonfer-
menting Gram-negative bacilli has been to establish a suscep-
tibility battery using Etest (bioMérieux) on Mueller-Hinton
agar following the CLSI interpretive standards for non-Enter-
obacteriaceae (7). The battery consists of six different antimi-
crobials: cefepime, ciprofloxacin, gentamicin, meropenem,
piperacillin-tazobactam, and trimethoprim-sulfamethoxazole.
This method was used to determine the antimicrobial suscep-
tibility of both K. gyiorum isolates, which were found to be
susceptible to all antimicrobials except ciprofloxacin (Table 1).
The first isolate was completely resistant by ciprofloxacin Etest,
with a MIC of 32 g/ml, while the second isolate tested as
resistant, with a MIC of 4 g/ml. Case reports of K. gyiorum
report susceptibility to ciprofloxacin, with MICs of approxi-
mately 1 g/ml, which is in contrast to our findings (5, 6). We
speculate that lack of compliance of the first patient with his
prescribed antimicrobial regimen may have selected for resis-
tance to ciprofloxacin in this isolate.
Due to the fact that a second bacterial species was isolated in
each of these two cases and because of the paucity of reports on
this organism in the literature, it is difficult to know how much
of the disease process can specifically be attributed to K. gyio-
rum. However, the first patient experienced progression of
symptoms while on an antimicrobial agent to which the isolate
was resistant; he then improved when treated with an agent to
which the organism was susceptible. This information provides
some evidence for the contribution of this organism to this
patient’s disease state.
In summary, we report two cases of K. gyiorum isolated from
human clinical specimens, from two different medical centers,
over a 2-month period. Although this organism has only previ-
ously been reported twice in the literature, this current report
suggests that it may be misidentified by laboratories that rely ex-
clusively on automated identification systems. With the emer-
gence of MALDI-TOF MS for microbial identification from clin-
ical specimens, it is possible that the reported frequency of
isolation of this organism may increase in the future.
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